Scientific research deductions and transfer pricing adjustments require proper statutory proof and comparability analysis before disallowance.
DSIR-certified capital scientific research expenditure qualified for the weighted deduction under section 35(2AB), and the denial of that additional benefit was set aside. Uncertified capital scientific research expenditure was also allowable as a normal deduction under section 35(1)(iv) where the research nexus was established by records and auditor-certified disclosures, so the disallowance was deleted. The transfer pricing adjustment underlying the section 80IC disallowance was found unsustainable because the Revenue relied on profit comparisons without a proper comparability analysis, including product mix, segmental differences and inter-unit transfer characteristics; the deduction was therefore upheld.
Issues: (i) Whether the assessee was entitled to additional weighted deduction on certified capital expenditure under section 35(2AB) of the Income-tax Act, 1961. (ii) Whether the uncertified capital scientific research expenditure was allowable as a normal deduction under section 35(1)(iv) of the Income-tax Act, 1961. (iii) Whether the transfer pricing adjustment leading to disallowance of deduction under section 80IC of the Income-tax Act, 1961 was sustainable.
Issue (i): Whether the assessee was entitled to additional weighted deduction on certified capital expenditure under section 35(2AB) of the Income-tax Act, 1961.
Analysis: The certified capital expenditure approved by the prescribed authority was to be given the weighted benefit contemplated by section 35(2AB). The order giving effect had allowed only the amount certified, without extending the statutory weighted component on the capital expenditure so certified.
Conclusion: The assessee was entitled to the additional 100% deduction on the DSIR-certified capital expenditure, and the denial to that extent was set aside.
Issue (ii): Whether the uncertified capital scientific research expenditure was allowable as a normal deduction under section 35(1)(iv) of the Income-tax Act, 1961.
Analysis: Once the expenditure was shown to be incurred on scientific research and was not disputed as such, the absence of DSIR certification for weighted deduction did not foreclose allowance of the capital expenditure at the normal rate. The contemporaneous records and auditor-certified disclosures were accepted as sufficient to establish the nexus with scientific research.
Conclusion: The uncertified capital scientific research expenditure was held allowable under section 35(1)(iv), and the disallowance to that extent was deleted.
Issue (iii): Whether the transfer pricing adjustment leading to disallowance of deduction under section 80IC of the Income-tax Act, 1961 was sustainable.
Analysis: The transfer pricing adjustment was found unsustainable because the taxpayer had maintained a transfer pricing study and the Revenue had not demonstrated specific defects warranting rejection. The comparison of margins from tax holiday units with non-eligible units, without properly accounting for product mix, segmental differences, and the nature of inter-unit transfers, was held impermissible on the facts.
Conclusion: The deletion of the transfer pricing adjustment and the resulting allowance of the section 80IC deduction was upheld.
Final Conclusion: The assessee succeeded on the scientific research deduction issues, and the Revenue failed on the transfer pricing based section 80IC disallowance. The composite result was that the assessee obtained full relief on the disputed issues before the Tribunal.
Ratio Decidendi: Where scientific research expenditure is factually established, the absence of weighted-deduction certification does not prevent allowance of the capital outlay at the normal statutory rate, and transfer pricing adjustments cannot rest on profit comparisons alone without a proper comparability analysis.